Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Ceribell, Inc.

NASDAQ: CBLL · Industrial Applications and Services · 6 alerts · CIK 1861107

Share price
$26.42Close, Nov 16
Market cap
$1.03B
Shares outstanding
38.84MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Electromedical & Electrotherapeutic ApparatusSIC 3845

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Ceribell, Inc. filings on SEC EDGAR ↗

6:11 PM ET Form 4
Insider Selling

Ceribell Director William W. Burke Sells $479K of Stock

William W. Burke, Director, sold 18,000 shares of Ceribell, Inc. at $26.58 to $27.48 a share (average $26.64) in 2 transactions, worth $479K in total on Nov 12, 2026. Shares held after the trade: 23,022 (-4.8%).

Value
$479K
Shares
18,000
Average price
$26.64
Role
Director
Holding change
-4.8%
Trade date
Nov 12, 2026
4:27 PM ET Form 4
Insider Selling

Ceribell Director Joseph Michael Taylor Sells $278K of Stock

Joseph Michael Taylor, Director, sold 10,200 shares of Ceribell, Inc. at $27.22 a share, worth $278K in total on Nov 9, 2026. Shares held after the trade: 38,278 (-21.0%).

Value
$278K
Shares
10,200
Price
$27.22
Role
Director
Holding change
-21.0%
Trade date
Nov 9, 2026
12:23 PM ET Form 4
Insider Selling

Ceribell CTO Raymond Woo Sells $132K of Stock

Raymond Woo, CTO, sold 4,887 shares of Ceribell, Inc. at $26.96 a share, worth $132K in total on Nov 2, 2026. Shares held after the trade: 203,118 (-2.3%).

Value
$132K
Shares
4,887
Price
$26.96
Role
CTO
Holding change
-2.3%
Trade date
Nov 2, 2026
4:51 PM ET 10-Q
Financial Results

Ceribell Q3 2026 Results: Net Loss of $21.4M, Loss Widens

Ceribell, Inc. reported total revenue of $29.3 million for the third quarter of 2026, representing a 30% increase year-over-year. However, the company experienced a net loss of $21.4 million for the quarter and $60.4 million for the first nine months of 2026, driven by significant increases in sales, marketing, and R&D expenses.

Key figure
Net loss $21.4M
4:37 PM ET 8-K
Financial Results

Ceribell Financial Results

Ceribell reported Q3 2026 total revenue of $29.3 million, a 30% year-over-year increase driven by record account additions and same-store utilization growth. The company achieved a 90% gross margin and ended the period with $117.5 million in cash and marketable securities. Key operational milestones included the full launch of its delirium monitoring solution and receiving FDA 510(k) clearance for new EEG analysis features.

Term
Q3 2026

“Our third quarter results reflect new highs in account additions and utilization within our existing account base, demonstrating the strength of our core seizure business as a durable growth engine. With the full launch of our delirium monitoring solution and the coming introduction of our new hardware platform, we are well positioned for a pivotal 2027 as we advance our mission to establish EEG as a new vital sign.”

Jane Chao, Ph.D., co-founder and CEO
5:20 PM ET Form 4
Insider Selling

Ceribell CTO Raymond Woo Sells $119K of Stock

Raymond Woo, CTO, sold 4,887 shares of Ceribell, Inc. at $24.38 a share, worth $119K in total on Oct 1, 2026. Shares held after the trade: 203,118 (-2.3%).

Value
$119K
Shares
4,887
Price
$24.38
Role
CTO
Holding change
-2.3%
Trade date
Oct 1, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.